Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy BTIG Research

Galmed Pharmaceuticals Ltd.
Start price
€0.30
18.03.24 / 50%
Target price
€55.09
18.03.25
Performance (%)
31.08%
Price
€0.39
06.05.24
Summary
This prediction is currently active. With a performance of 31.08% the BUY prediction by BTIG_Research is a big success. This prediction currently runs until 18.03.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. 6.593% 6.593%
iShares Core DAX® 0.476% -0.039%
iShares Nasdaq 100 1.290% 0.504%
iShares Nikkei 225® 1.300% -2.135%
iShares S&P 500 0.829% 0.193%

Comments by BTIG_Research for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) 31.08%
Target price 55.086
Change
Ends at 18.03.25

Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $60.00 price target on the stock.
Ratings data for GMED provided by MarketBeat

BTIG Research 
0
Report Share
18.03.24